Showing posts with label Quality. Show all posts
Showing posts with label Quality. Show all posts

Friday, May 4, 2012

Hospital-Physician Alignment Improves Health Care Quality, Creates $13.2M Savings

WASHINGTON, May 3, 2012 /PRNewswire/ -- Two hospitals and one health system are now delivering improved clinical outcomes at lower cost, thanks to a concerted move toward accountable care that promotes hospital-physician collaboration and leverages physician-level cost and quality performance data. 

(Logo: http://photos.prnewswire.com/prnh/20110802/PH45999LOGO )

On May 3 in Orlando, The Advisory Board Company will honor these institutions with the 2012 Crimson Physician Partnership Award for improving the quality of care they provide while documenting more than $13.2 million in aggregate savings: 

Virginia Hospital Center (Arlington),Alegent Health (Omaha), and Monmouth Medical Center (Long Branch, N.J.).

The award presentation will take place at the Crimson Annual Performance Summit at the JW Marriott Orlando Grande Lakes in Orlando.  The awards, now in their third year, are presented to administrator-physician leadership teams at organizations that are members of the Crimson physician performance technologies cohort.  Crimson (R) is a program from The Advisory Board Company that helps hospitals and health systems advance quality goals and secure cost savings by eliminating inefficiencies in care delivery. 

Virginia Hospital Center Improves Clinical Documentation

The 342-bed facility found that its clinical documentation often did not reflect the complexity of pneumonia being treated.  At the same time, the hospital was experiencing financial losses due to fast-rising numbers of Medicare patients, and physician performance data showed that the greatest losses were occurring across ventilated patients.  The institution utilized quality and cost performance data to engage physicians on improving documentation and clinical performance, resulting in a 38% decrease in its mortality observed/expected ratio, a 14% decrease in average length of stay , and a 26% reduction in cost per case.  The net financial impact of the efforts was annualized savings of more than $635,000. 

"We have been preparing Virginia Hospital Center and our physicians for a new era of public accountability when consumers will have unprecedented access to a wide range of data such as readmissions and patient surveys," said Jeffrey DiLisi, MD, Vice President and Chief Medical Officer at Virginia Hospital Center.  "We have had success with our physicians in improving clinical documentation–and the resulting care outcomes–because our physicians have been able to see the impact on quality of care and on their great reputations.  Crimson has enabled us to make performance data transparent so we can eliminate documentation errors and move toward breaking even on Medicare cases." 

Alegent Health Enhances Care Effectiveness and Efficiency

This 10-hospital health system has physicians and nurses aligned to collaborate with interdisciplinary care teams at each of its facilities to reduce unnecessary utilization of medical resources.  The system's 100-day "Care Redesign" projects have yielded more than $2 million in annualized savings.  The system also improved or maintained 98.9% of its quality metrics for targeted diagnoses; further, patient experience scores showed a record improvement.  For example, Alegent Health Lakeside Hospital, a 157-bed hospital in Omaha, focused on nonhemorrhagic stroke patients and eliminated complications of care for 13 months. 

"Our culture of clinical improvement has grown with rapid-cycle Care Redesign projects," said Rick Miller, DO, Senior Vice President and Chief Quality Officer, Alegent Health.  "For each diagnosis-specific project, case managers, nurses, physicians, and therapists work together to identify a specific opportunity to reduce resource utilization and meet weekly with a system-level steering committee to discuss progress and results.  It's a repeatable process that has allowed us to share best practices across the system and among physicians.  This never would have been possible without Crimson's outstanding tool for collaboration with clinicians." 

Monmouth Medical Center Lifts Clinical Effectiveness Institutionwide

Since 2008, this 527-bed teaching hospital has developed care efficiency initiatives across clinical areas such as joint replacements, vaginal deliveries, and heart failure.  In addition to contributing $10.6 million in cost savings, these projects have also driven widespread improvement in key quality measures.  In 2007 Monmouth ranked among the top 10% of U.S. hospitals on 16 of 24 core measures for quality (67%) but in 2011 did so on 23 of 24 core measures (96%). 

"For decades we've been working to improve care quality while reducing costs," said Thomas Heleotis, MD, VP of Clinical Effectiveness for Monmouth Medical Center.  "The breakthrough came when we were able to engage physicians on their performance data through the use of Crimson.  Now that physicians can easily look up their own data and track their performance, they can see clear, actionable steps for clinical improvement." 

Out of a national Crimson cohort of more than 550 individual hospitals representing more than 360,000 physicians, these three institutions have distinguished themselves as leaders in care efficiency.  "The Physician Partnership Award winning- institutions have made key, long-term organizational gains that will benefit patients and their communities," said Paul Roscoe, CEO, Crimson.  "By engaging their physicians in meaningful ways through quality and cost performance data, these institutions have strengthened the alignment needed to succeed under risk-based payments from private and public payers." 

For more information on the 2012 Crimson Physician Partnership Awards, including videos on the award winners, visit http://www.advisory.com/award. 

About Virginia Hospital Center

For over 60 years, Virginia Hospital Center has provided exceptional medical services to the Washington metropolitan area.  Virginia Hospital Center is a 342-bed, $150 million state-of-the-art facility offering comprehensive healthcare and multiple Centers of Excellence including Cardiology & Cardiovascular Surgery, the Reinsch Pierce Family Center for Breast Health, Neuroscience, Oncology, Total Joint Replacement (hip and knee), Women & Infant Health and Urology.  Growing service lines include Executive Health and the only Lung Cancer Center in northern Virginia.  Virginia Hospital Center is a teaching hospital, long-associated with Georgetown University's School of Medicine, and accredited by The Joint Commission and Licensed by the Commonwealth of Virginia Department of Health.  For additional information, please visit www.VirginiaHospitalCenter.com.

About Alegent Health

With a commitment to providing high-quality care and an exceptional patient experience, Alegent Health, its 1,300 physicians and 8,600 employees are focused on caring for the body, mind and spirit of every person. Patients find a continuum of care at Alegent Health, from primary care through geriatrics. Families can also find specialty care at Alegent Health including women's and children's, cardiovascular, orthopedics, spine, oncology, physical rehabilitation and behavioral health services. With the blessing of our sponsors, Catholic Health Initiatives and Immanuel, Alegent Health has 10 hospitals, freestanding inpatient psychiatric and skilled nursing facilities and more than 100 sites of service making us the largest not-for-profit, faith-based healthcare provider in Nebraska and southwest Iowa. For more information, visit www.alegent.com.

About Monmouth Medical Center

Monmouth Medical Center, an affiliate of Barnabas Health, along with the Children's Hospital at Monmouth Medical Center, is one of New Jersey's largest academic medical centers and has been a teaching affiliate of Philadelphia's Drexel University College of Medicine for more than 40 years.  From its earliest days, Monmouth Medical Center has been a leader in surgical advancement and has introduced many technological firsts to the region, including robotic surgery and other minimally invasive techniques.  The hospital is routinely recognized by HealthGrades, the nation's largest premier independent health care quality company, for excellence in both emergency medicine and maternity care.  U.S. News & World Report has recognized Monmouth as a regional leader in cancer, geriatrics, gynecology, neurology and neurosurgery.  For more information on Monmouth Medical Center, visit www.barnabashealth.org.

About The Advisory Board Company

The Advisory Board Company is a global technology, research, and consulting firm partnering with 125,000 leaders in 3,700 organizations across health care and higher education. Through its innovative membership model, the firm collaborates with executives and their teams to elevate performance and solve their most pressing challenges.  The company provides strategic guidance, actionable insights, web-based software solutions, and comprehensive implementation and management services.  Through its Crimson offerings, The Advisory Board Company collaborates with health care providers dedicated to strengthening hospital-physician alignment, coordination among care settings, and overall clinical performance.  Combining business intelligence technology with best practice implementation, Crimson offerings are developed with hospitals, health systems, physicians, and other practitioners seeking improved alignment on key clinical, operational and strategic goals.  For more information about The Advisory Board Company, visit http://www.advisory.com.


View the original article here

U.S. Health Care Spending High, But Quality Lags: Report

THURSDAY, May 3 (HealthDay News) -- Despite the fact that Americans spend more on their health care than citizens of 12 other developed nations, a new report finds that more does not necessarily equal better when it comes to quality of care.

The Commonwealth Fund report, led by senior research associate David Squires, revealed that the United States is shelling out roughly $8,000 per capita for health care, according to 2009 figures. By contrast, the Japanese and New Zealanders spend just one-third of that amount on health care, while Norwegians and the Swiss cough up about two-thirds.

Yet Americans now fare the worst in terms of preventable asthma fatalities among patients aged 5 to 39. The country also ranks poorly -- alongside Germany -- in diabetes-related amputations. As for in-hospital heart attack and stroke death rates, the United States stacks up as average at best.

"It is a common assumption that Americans get more health care services than people in other countries, but in fact we do not go to the doctor or the hospital as often," Squires said in a Commonwealth Fund news release. "The higher prices we pay for health care and perhaps our greater use of expensive technology are the more likely explanations for high health spending in the U.S. Unfortunately, we do not seem to get better quality for this higher spending."

Released on Thursday, the report analyzed health spending in Sweden, Australia, New Zealand, France, Canada, Germany, Norway, Japan, Switzerland, Denmark, the Netherlands and the United Kingdom, as well as the United States -- the only nation among those studied that does not provide universal health care.

The authors found that in 2009, the United States ranked No. 1 (followed by the Netherlands) in the proportion of its gross domestic product devoted to health care: a full 17 percent. By comparison, the other countries in the report spent 12 percent or less, with Japan ranking as the lowest spender at about 9 percent.

Despite their country's spending, Americans can expect poorer access to physicians than people in other industrialized nations, with just 2.4 doctors for every 100,000 citizens. On that score, only Japan fared worse, according to the report.

Other troubling indicators included the fact that Americans also have the second-worst rate of physician consultations (behind Sweden), relatively few hospital beds, fairly short hospital stays in acute-care situations and a low rate of hospital discharges.

It wasn't all bad news, however. The United States is No. 1 in survival rates among breast cancer patients. It also shares the top spot (with Norway) for survival rates among colorectal cancer patients.

But when it comes to both hospital and prescription drug costs, Americans are at the highest peak by far.

By the time a U.S. patient is discharged from a hospital, he or she will have cost the health care system about $18,000 on average. Care for a similar Canadian patient comes to just $13,000, while in many other countries (Sweden, Australia, New Zealand, France and Germany) it dips below $10,000.

When comparing the cost of the 30 most common prescription medications, the report found that Americans are paying one-third more than Canadians and Germans, and twice as much as their Australian, French, Dutch, British and New Zealand counterparts.

Americans can take some solace in the report's observation that every nation in the study is battling a trend of ever-increasing health care costs. Karen Davis, president of the Commonwealth Fund, noted that recent legislative changes have the potential to help improve the financials of health care across the country.

"The Affordable Care Act gives us the opportunity to build a health care system that delivers affordable, high-quality care to all Americans," Davis said in the news release. "To achieve that goal, the United States must use all of the tools provided by the law, including new methods of organizing, delivering and paying for health care, that will help to slow the growth of health care costs while improving quality."

More information

Visit the World Health Organization to learn about global health expenditure.


View the original article here

Sunday, April 29, 2012

Accretive Health Announces Termination of its Quality and Total Cost of Care Services Contract by Fairview Health ...

CHICAGO--(BUSINESS WIRE)--

Accretive Health, Inc. (NYSE: AH - News) said today that it has received notice of termination from Fairview Health Services of its Quality and Total Cost of Care (“QTCC”) services contract. The terms of the transition have yet to be determined. The Company will update its business outlook on its quarterly earnings call on May 9, 2012.

Accretive Health said that it regrets that the recent activities of the Minnesota Attorney General have created a situation where Fairview felt it necessary to cancel its work with the Company in QTCC. The Company intends to work with Fairview to preserve the good results that have been achieved and will continue to invest in this important area.

Accretive Health also said it has received reiterations of support from other clients who recognize the value of Accretive Health’s ability to help hospitals and other healthcare providers enhance their quality of care. This show of support is consistent with the Company’s mission of being a constructive and positive contributor to the American healthcare system.

About Accretive Health

Accretive Health partners with healthcare providers to help them more effectively manage their revenue cycles, strengthen their financial stability, and improve the quality of care they provide while reducing overall healthcare costs. Our people, processes and sophisticated integrated technology complement our clients' existing resources to enhance results for patients, physicians and staff. For more information, please visit www.accretivehealth.com.

Safe Harbor Statement

This document contains forward-looking statements, including statements regarding outstanding issues with the Minnesota Attorney General and the Company’s efforts to facilitate an orderly transition of its QTCC services at Fairview Health Services, which involve risks and uncertainties. Our actual results could differ materially from those anticipated in these forward-looking statements as a result of various factors, including those set forth in our Annual Report on Form 10-K filed with the SEC on February 29, 2012, under the heading "Risk Factors". The words "anticipates," "believes," "estimates," "expects," "intends," "may," "plans," "projects," "would," “will,” and similar expressions are intended to identify forward-looking statements, although not all forward-looking statements contain these identifying words. We have based these forward-looking statements on our current expectations and projections about future events. Although we believe that the expectations underlying any of our forward-looking statements are reasonable, these expectations may prove to be incorrect and all of these statements are subject to risks and uncertainties. Should one or more of these risks and uncertainties materialize, or should underlying assumptions, projections, or expectations prove incorrect, actual results, performance, financial condition, or events may vary materially and adversely from those anticipated, estimated, or expected.

All forward-looking statements included in this report are expressly qualified in their entirety by the foregoing cautionary statements. We wish to caution readers not to place undue reliance on any forward-looking statement that speaks only as of the date made and to recognize that forward-looking statements are predictions of future results, which may not occur as anticipated. Actual results could differ materially from those anticipated in the forward-looking statements and from historical results, due to the uncertainties and factors described above, as well as others that we may consider immaterial or do not anticipate at this time. Although we believe that the expectations reflected in our forward-looking statements are reasonable, we do not know whether our expectations will prove correct. Our expectations reflected in our forward-looking statements can be affected by inaccurate assumptions we might make or by known or unknown uncertainties and factors, including those described above. The risks and uncertainties described above are not exclusive, and further information concerning us and our business, including factors that potentially could materially affect our financial results or condition or relationships with customers and potential customers, may emerge from time to time. We assume no, and we specifically disclaim any, obligation to update, amend, or clarify forward-looking statements to reflect actual results or changes in factors or assumptions affecting such forward-looking statements. We advise you, however, to consult any further disclosures we make on related subjects in our periodic reports that we file with or furnish to the U.S. Securities and Exchange Commission.


View the original article here

Friday, March 16, 2012

NCQA Honors Health Quality Leaders

Fri, Mar 16, 2012, 8:14 AM EDT - U.S. Markets open in 1 hr 16 mins

Sorry, I could not read the content fromt this page.

View the original article here